The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal sequencing of TCR and circulating tumor DNA revealing radiotherapeutic efficacy and prognosis for non-small cell lung cancer patients with brain metastasis.
 
Xiaorong Dong
No Relationships to Disclose
 
Lingjuan Chen
No Relationships to Disclose
 
Fan Tong
No Relationships to Disclose
 
Chunhua Wei
No Relationships to Disclose
 
Han Wang
No Relationships to Disclose
 
Xuefeng Xia
No Relationships to Disclose
 
Yaping Xu
No Relationships to Disclose
 
Pian Liu
No Relationships to Disclose
 
Zhongxing X. Liao
Honoraria - Varian Medical Systems
Speakers' Bureau - Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems
 
Jianjun Zhang
Honoraria - CancerNet; Geneplus; Geneplus; innovent biologics; Innovent Biologics; Origimed; Roche; Sino-USA Biomedical Platform; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Capital Medical University; Geneplus; Johnson & Johnson/Janssen
Research Funding - Merck
Travel, Accommodations, Expenses - innovent biologics; Zhejiang Cancer Hospital
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Nexus Pharmaceuticals Inc
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; GlaxoSmithKline; Helsinn Therapeutics; Incyte; Inivata; Inovio Pharmaceuticals; Janssen; Kyowa Hakko Kirin; Loxo; Merck; Novartis; Pfizer; Takeda
Research Funding - Bristol-Myers Squibb